IS2915B - Ferli til að stýra kristalbyggingu rísedrónats - Google Patents

Ferli til að stýra kristalbyggingu rísedrónats

Info

Publication number
IS2915B
IS2915B IS8262A IS8262A IS2915B IS 2915 B IS2915 B IS 2915B IS 8262 A IS8262 A IS 8262A IS 8262 A IS8262 A IS 8262A IS 2915 B IS2915 B IS 2915B
Authority
IS
Iceland
Prior art keywords
risedronate
crystal structure
controlling crystal
controlling
hydrate
Prior art date
Application number
IS8262A
Other languages
English (en)
Other versions
IS8262A (is
Inventor
Jane Ellen Godlewski
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of IS8262A publication Critical patent/IS8262A/is
Publication of IS2915B publication Critical patent/IS2915B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Pens And Brushes (AREA)
IS8262A 2003-07-30 2006-01-25 Ferli til að stýra kristalbyggingu rísedrónats IS2915B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49122203P 2003-07-30 2003-07-30
PCT/US2004/022703 WO2005012314A1 (en) 2003-07-30 2004-07-15 Process for controlling crystal structure of risedronate

Publications (2)

Publication Number Publication Date
IS8262A IS8262A (is) 2006-01-25
IS2915B true IS2915B (is) 2014-12-15

Family

ID=34115482

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8262A IS2915B (is) 2003-07-30 2006-01-25 Ferli til að stýra kristalbyggingu rísedrónats

Country Status (20)

Country Link
US (1) US7002014B2 (is)
EP (1) EP1651656B1 (is)
JP (1) JP4423614B2 (is)
KR (1) KR100786044B1 (is)
CN (1) CN100439377C (is)
AT (1) ATE493423T1 (is)
AU (1) AU2004261561B9 (is)
BR (1) BRPI0413067A (is)
CA (1) CA2529470C (is)
CO (1) CO5660304A2 (is)
DE (1) DE602004030801D1 (is)
IL (1) IL172676A (is)
IS (1) IS2915B (is)
MA (1) MA27914A1 (is)
MX (1) MXPA06001129A (is)
NO (1) NO335393B1 (is)
NZ (1) NZ544030A (is)
RU (1) RU2319706C2 (is)
SG (1) SG144151A1 (is)
WO (1) WO2005012314A1 (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア 3−ピリジル−1−ヒドロキシエチリデン−1、1−ビスホスホン酸ナトリウム塩2.5水和物a型結晶の製造方法
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Adeka スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
KR20090005206A (ko) 2006-05-11 2009-01-12 인드-스위프트 래버러토리즈 리미티드 순수한 리세드론산 또는 염의 제조 방법
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) * 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100812528B1 (ko) * 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
KR100274734B1 (ko) * 1991-11-22 2000-12-15 제이코버스 코넬리스 레이서 리제드로네이트 지연-방출성 조성물
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate

Also Published As

Publication number Publication date
CN100439377C (zh) 2008-12-03
CO5660304A2 (es) 2006-07-31
KR20060054297A (ko) 2006-05-22
NO20060950L (no) 2006-02-27
IL172676A0 (en) 2006-04-10
SG144151A1 (en) 2008-07-29
DE602004030801D1 (de) 2011-02-10
AU2004261561B2 (en) 2008-06-26
ATE493423T1 (de) 2011-01-15
MA27914A1 (fr) 2006-05-02
NZ544030A (en) 2008-05-30
MXPA06001129A (es) 2006-04-11
CA2529470A1 (en) 2005-02-10
US7002014B2 (en) 2006-02-21
RU2319706C2 (ru) 2008-03-20
AU2004261561A1 (en) 2005-02-10
KR100786044B1 (ko) 2007-12-17
WO2005012314A1 (en) 2005-02-10
IL172676A (en) 2010-12-30
RU2006102357A (ru) 2006-07-27
JP4423614B2 (ja) 2010-03-03
US20050026869A1 (en) 2005-02-03
BRPI0413067A (pt) 2006-10-17
IS8262A (is) 2006-01-25
EP1651656A1 (en) 2006-05-03
NO335393B1 (no) 2014-12-08
JP2007500189A (ja) 2007-01-11
CN1823078A (zh) 2006-08-23
CA2529470C (en) 2010-11-23
EP1651656B1 (en) 2010-12-29
AU2004261561B9 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
IS2915B (is) Ferli til að stýra kristalbyggingu rísedrónats
HUP0204203A2 (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
ATE497769T1 (de) Verfahren zur herstellung von ibandronat
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
EA200900779A1 (ru) Производные дигидропиридина, полезные как ингибиторы протеинкиназы
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
DK1539711T3 (da) Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
WO2003106416A3 (en) CHEMICAL PROCESS
IL172513A0 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
UA89057C2 (ru) Способы получения полиморфных форм мезотриона и применение регулирования рн
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
EA200701852A1 (ru) Производные аминокислот
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
ATE485255T1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
ZA200800138B (en) Process for the preparation of crystalline perindopril
FI20045307A (fi) Kipsilevyn pinnoite ja kipsilevy
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
WO2006081543A3 (en) Crystalline phosphatase and method for use thereof
ATE414694T1 (de) Neue heterocyclylethylbenzamid-derivate
HUP0204491A2 (hu) Eljárás 4-amino-ftálimid előállítására
ATE397603T1 (de) Herstellungsverfahren von kristallinem losartan- kaliumsalz